Patient-reported outcomes (PRO) are defined as reports coming directly from patients about how they feel or function in relation to a health condition and its therapy. Although there are numerous compelling reasons why PRO could be an important help in clinical care, they have not evolved into clinical tools integrated into care. The purpose of this review is to assess existing PRO instruments for heart failure with respect to their psychometric properties and potential for use in clinical care. We performed a systematic search of articles published between July 2008 and January 2015 within the MEDLINE, PROMIS, PROQOLID, and Cochrane Library databases. Included instruments had to be developed and tested for heart failure and have had their development processes and psychometric properties described. A total of 31 instruments were identified, 9 of which met all inclusion criteria. After evaluating each remaining instrument in terms of psychometric and clinical criteria and symptom coverage, only 2 instruments-Minnesota Living with Heart Failure and Kansas City Cardiomyopathy questionnaire-met all evaluation criteria. Although clinically useful PRO instruments exist, increasing education to providers on the value and interpretability of PRO instruments, as well as a more streamlined Patents: 7,643,969; 7, 853,456; 12/965,656; 13/615,401 Because PRO are often questionnaires completed by patients, they have been previously considered as "soft" endpoints. However, it should be noted that the "hardness" of data has been defined as its reproduc- JACC: HEART FAILURE VOL. 4, NO. 3, 2016 Kelkar et al. and January 31, 2015. We searched the MEDLINE, I n c l u s i o n a n d e x c l u s i o n c r i t e r i a . Studies could be cross-sectional or longitudinal, but they had to study HF patients and be reported in English. The studies had to measure HF symptoms and describe the development process and psychometric properties ( Table 1) . Only instruments developed and tested for HF were included, while generic instruments as they are less sensitive to HF changes than HF-specific in- The relevant articles for each instrument were evaluated for whether there was evidence to fulfill these criteria. Lastly, the questions and concepts of each PRO instrument were cross-matched with a list of HF-specific symptom endpoints ( Table 2) . Each PRO was evaluated for whether it addressed HF as well as other detrimental symptoms that HF patients routinely experience.
THE HISTORY OF PATIENT-REPORTED OUTCOMES IN CLINICAL PRACTICE
PRO are defined as reports coming directly from patients about how they feel or function in relation to a health condition and its therapy, without interpretation by health care providers or anyone else (8) Developed in the mid-1980s, the Minnesota Living with Heart Failure Questionnaire (MLHFQ) is considered to be among the first HF PRO and is among the most widely used after being validated for use as an outcome in clinical trials (12) . The Kansas City Cardiomyopathy Questionnaire (KCCQ) was developed almost a decade later and is now the most widely used HF PRO and has recently been shortened to a 12-item version to support its use in clinical care (13) . Despite the existence of these PRO for more than 2 decades, they are still not routinely integrated in clinical care. There are reasons to believe that PRO would be an important metric for high-quality care, Because PRO are often questionnaires completed by patients, they have been previously considered as "soft" endpoints. However, it should be noted that the "hardness" of data has been defined as its reproducibility (16) , and PRO have shown to be more reproducible than other clinical trial measures such as assessments of ejection fraction or valve gradients (9, 10 and January 31, 2015. We searched the MEDLINE, I n c l u s i o n a n d e x c l u s i o n c r i t e r i a . Studies could be cross-sectional or longitudinal, but they had to study HF patients and be reported in English. The studies had to measure HF symptoms and describe the development process and psychometric properties ( Table 1) . Only instruments developed and tested for HF were included, while generic instruments as they are less sensitive to HF changes than HF-specific in- The relevant articles for each instrument were evaluated for whether there was evidence to fulfill these criteria. Lastly, the questions and concepts of each PRO instrument were cross-matched with a list of HF-specific symptom endpoints ( Table 2) . Each PRO was evaluated for whether it addressed HF as well as other detrimental symptoms that HF patients routinely experience.
RESULTS. I n s t r u m e n t s c h a r a c t e r i s t i c s . Table 3 E v a l u a t i o n c r i t e r i a . Table 4 presents a summary of the details of each instrument, as well as whether or not they fulfilled the evaluation criteria. Of the 9 instruments studied, only 2 fit all of the evaluation criteria-the KCCQ and the MLHFQ. Table 2 . Tables 1 to 3 . E-mail: javed.butler@stonybrookmedicine.edu.
